Genolution Inc. (KOSDAQ:225220)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Biotechnology	9.76B	38.08B
Biotechnology Growth	-74.37%	-
Total	9.76B	38.08B
Total Growth	-74.37%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
South Korea	9.76B	38.08B
South Korea Growth	-74.37%	-
Total	9.76B	38.08B
Total Growth	-74.37%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 18, 2026

Data Sources Report a data error